A Lesson to Learn o...
Health Care: Drugs
Insmed Inc. (INSM: NASDAQ)
$12.76 -0.02 | -0.16%
06/18/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 90.78M | 14.85M | 10.74M | 12.74M |
| Receivables | 0.00 | 757.00K | 471.00K | 2.27M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 2.15M | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 93.58M | 77.40M | 108.80M | 124.61M |
| Property, Plant & Equipment, Gross | 4.55M | 4.29M | 1.10M | 0.00 |
| Accumulated Depreciation & Depletion | 2.88M | 2.35M | 0.00 | 0.00 |
| Property, Plant & Equipment, Net | 1.67M | 1.94M | 1.10M | 0.00 |
| Intangibles | 58.20M | 58.20M | 0.00 | 0.00 |
| Other Non-Current Assets | 117.00K | 2.30M | 80.08M | 2.09M |
| Total Non-Current Assets | 59.98M | 62.43M | 87.47M | 2.09M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 153.56M | 139.83M | 196.26M | 126.70M |
| Accounts Payable | 7.06M | 2.33M | 1.45M | 312.00K |
| Short Term Debt | 3.10M | 114.00K | 81.00K | 208.00K |
| Other Current Liabilities | 0.00 | 156.00K | 0.00 | 0.00 |
| Total Current Liabilities | 15.75M | 4.48M | 3.34M | 2.78M |
| Long Term Debt | 16.22M | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 16.93M | 1.09M | 83.00K | 0.00 |
| Total Liabilities | 32.68M | 5.57M | 3.42M | 2.78M |
| Preferred Stock Equity | 0.00 | 0.00 | 918.00K | 0.00 |
| Common Stock Equity | 120.88M | 134.27M | 191.92M | 123.91M |
| Common Par | 315.00K | 248.00K | 1.56M | 1.30M |
| Additional Paid In Capital | 456.12M | 427.74M | 423.88M | 350.24M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -335.55M | -294.17M | -234.51M | -228.08M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 450.00K | 993.00K | 445.00K |
| Total Capitalization | 137.10M | 134.27M | 192.84M | 123.91M |
| Total Equity | 120.88M | 134.27M | 192.84M | 123.91M |
| Total Liabilities & Stock Equity | 153.56M | 139.83M | 196.26M | 126.70M |
| Total Common Shares Outstanding | 31.49M | 24.83M | 15.65M | 13.02M |
| Preferred Shares | 0.00 | 0.00 | 9.17M | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 26.54M | 23.35M | 13.25M | 12.71M |
| Diluted Weighted Shares Outstanding | 26.54M | 23.35M | 13.25M | 12.73M |
| Number of Employees | 41 | 42 | 40 | 15 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with INSM
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- Userbetterlatethannever
- UserStock Choices
- Userjstanley Portfolio 1
- Userlgselsorlaw Portfolio 1
- Userkazooskibum
- Usersmercado
- UserMr. T fund
- UserLorirain II
Latest INSM Headlines from TheStreet
- Biotech Stock Mailbag: 2013 Clinical Trials Calendar 06.07.13 | 07:06 am
- Programmed Insider Buying? Yes, at Insmed and United Therapeutics 01.24.13 | 08:01 am
- 4 Plays Under $10 on the Rise 11.13.12 | 05:11 pm
- Insmed's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.07.12 | 01:08 pm
- 5 Under-$10 Stocks Poised for a Breakout 06.07.12 | 02:06 pm
- Insmed Stock Gaps Down On Today's Open (INSM) 10.10.11 | 09:10 am
- Insmed Inc. Stock Downgraded (INSM) 08.22.11 | 08:08 am
- Insmed Stock Soars (INSM) 08.11.11 | 03:08 pm
- 'Strong Rally' in Small-Caps May Emerge 08.09.11 | 10:08 am
- Insmed Stock Gaps Down On Today's Open (INSM) 08.02.11 | 09:08 am
Press Releases for INSM
- The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Insmed Incorporated In Connection With Executive Compensation - PR Newswire 01.17.13 | 02:01 pm
- Insmed To Present At 31st Annual J.P. Morgan Healthcare Conference - PR Newswire 12.13.12 | 08:12 am
- Insmed Announces CLEAR-108 Phase 3 Clinical Study Of ARIKACE® In Cystic Fibrosis Patients With Pseudomonas Lung Infections Has Completed Target Enrollment - PR Newswire 11.13.12 | 08:11 am
- Insmed To Present At Two Upcoming Investor Conferences - PR Newswire 11.12.12 | 08:11 am
- Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler As Chief Financial Officer - PR Newswire 11.07.12 | 07:11 am
- Insmed Appoints Will Lewis As President And Chief Executive Officer - PR Newswire 09.11.12 | 08:09 am
- Insmed To Present At Stifel Nicolaus 2012 Healthcare Conference - PR Newswire 08.30.12 | 08:08 am
- Insmed To Present At 2012 Wedbush PacGrow Life Sciences Management Access Conference - PR Newswire 08.14.12 | 08:08 am
- Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of Directors - PR Newswire 08.06.12 | 08:08 am
- Insmed Receives Second Composition Of Matter Patent For ARIKACE® - PR Newswire 08.02.12 | 08:08 am
Partner Headlines for INSM
- Benzinga's Microcap Movers for Friday January 20, 2012 - Benzinga 01.22.12 | 10:01 am
- November's Low Price To Book Stocks Vs. Bankruptcy Risks - Seeking Alpha 11.04.11 | 08:11 am
- BMS Drug Deemed Too Costly: Weekly Round-Up Of Biotech Failures And Mishaps - Seeking Alpha 10.16.11 | 08:10 am
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am
- Thursday's Top Performing Small Cap Stocks (AONE, AIQ, KV.A, INSM, CXPO) - NASDAQ 08.12.11 | 03:08 pm
- 6 Stocks With New Uptrends - Seeking Alpha 05.26.11 | 07:05 am
- Portfolio Moves in a Volatile Market - Seeking Alpha 05.09.10 | 05:05 am
